https://www.selleckchem.com/pr....oducts/vorapaxar.htm
iated with a higher risk of mortality in inflammatory bowel disease patients with pneumonia. This is the first study to identify predictors of mortality in inflammatory bowel disease patients with pneumonia. The rate of mortality and hospitalization duration of stay were similar among inflammatory bowel disease and non-inflammatory bowel disease patients. Use of opioids and presence of bronchiectasis were associated with a higher risk of mortality in inflammatory bowel disease patients with pneumonia. Endoscopic submucosal dissection